Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Marco

Showing results (121-130 of 126) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 126 results.
British Journal of Pharmacology|October 22, 2011
Mechanism of action of a nanomolar potent, allosteric antagonist of the thyroid-stimulating hormone receptorChris J van Koppen, Marcel E de Gooyer, Willem-Jan Karstens, et al.
Biochemical Pharmacology|February 19, 2013
Signaling of an allosteric, nanomolar potent, low molecular weight agonist for the follicle-stimulating hormone receptorChris J van Koppen, Pieter M Verbost, Ruud van de Lagemaat, et al.
Molecular Pharmaceutics|January 31, 2015
Design, Synthesis, and Evaluation of Linker-Duocarmycin Payloads: Toward Selection of HER2-Targeting Antibody-Drug Conjugate SYD985Ronald C Elgersma, Ruud G E Coumans, Tijl Huijbregts, et al.
Bioorganic & Medicinal Chemistry|March 31, 2023
Discovery of SYD5115, a novel orally active small molecule TSH-R antagonistWillem F J Karstens, Wiro M B P Menge, Gijs Martens, et al.
Molecular Cancer Therapeutics|June 4, 2016
SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody-Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu ExpressionJonathan Black, Gulden Menderes, Stefania Bellone, et al.
Plos One|November 16, 2012
Org 214007-0: a novel non-steroidal selective glucocorticoid receptor modulator with full anti-inflammatory properties and improved therapeutic indexMarie-José C van Lierop, Wynand Alkema, Anke J Laskewitz, et al.
Pageof 13

Showing results (121-130 of 126) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 126 results.
British Journal of Pharmacology|October 22, 2011
Mechanism of action of a nanomolar potent, allosteric antagonist of the thyroid-stimulating hormone receptorChris J van Koppen, Marcel E de Gooyer, Willem-Jan Karstens, et al.
Biochemical Pharmacology|February 19, 2013
Signaling of an allosteric, nanomolar potent, low molecular weight agonist for the follicle-stimulating hormone receptorChris J van Koppen, Pieter M Verbost, Ruud van de Lagemaat, et al.
Molecular Pharmaceutics|January 31, 2015
Design, Synthesis, and Evaluation of Linker-Duocarmycin Payloads: Toward Selection of HER2-Targeting Antibody-Drug Conjugate SYD985Ronald C Elgersma, Ruud G E Coumans, Tijl Huijbregts, et al.
Bioorganic & Medicinal Chemistry|March 31, 2023
Discovery of SYD5115, a novel orally active small molecule TSH-R antagonistWillem F J Karstens, Wiro M B P Menge, Gijs Martens, et al.
Molecular Cancer Therapeutics|June 4, 2016
SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody-Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu ExpressionJonathan Black, Gulden Menderes, Stefania Bellone, et al.
Plos One|November 16, 2012
Org 214007-0: a novel non-steroidal selective glucocorticoid receptor modulator with full anti-inflammatory properties and improved therapeutic indexMarie-José C van Lierop, Wynand Alkema, Anke J Laskewitz, et al.
Pageof 13